
Allena Ji
• Specialties in strategies of transferring clinical trial biomarkers and Immunogenicity assays (ADAs) to clinical diagnostic labs under CLIA... | 74 School Street, Hopkinton, United States
*50 free lookup(s) per month.
No credit card required.
Allena Ji’s Emails al****@ge****.com
Allena Ji’s Phone Numbers No phone number available.
Social Media
Allena Ji’s Location 74 School Street, Hopkinton, United States
Allena Ji’s Expertise • Specialties in strategies of transferring clinical trial biomarkers and Immunogenicity assays (ADAs) to clinical diagnostic labs under CLIA 88 regulation in the US and ISO certificates in the EU. Expert in project management of bioanalysis, CRO monitoring, and compliance of GLP, GCLP, and GCP, in bioanalysis, CLIA lab operations for rare disease applications. • Significant function roles in supporting the launches of Eliglustat, Vanglustat, Xenpozyme, Fabrazyme, Lamzede, Elfabrio for Gaucher, AMSD, Fabry, Alfa-mannosidosis rare diseases (enzyme replacement therapy). • Over 20 years of the pharmaceutical industry and CRO work experience in Bioanalysis for supporting Biomarkers/PK and large molecule studies with GLP and GCLP compliance. • American Board Certified for Clinical Chemistry (DABCC), has work experience as CLIA Lab Director, Director of Biomarker of LC/MS/MS labs, and Director of global diagnostics. • Excellent leadership, interpersonal, and communication, presentation skills in collaborating with multiple teams of clinical trial operations, bioanalysis, and CROs business. • A leading author for 40+ publications and a speaker at worldwide conferences. • Invited Speaker for WRIB ( Workshop Recent Issues on Bioanalysis) for last 6 years consecutively
Allena Ji’s Current Industry Chiesi Usa
Allena
Ji’s Prior Industry
Kansas City Bioanalytical Services
|
Pfizer
|
Wuxi Apptec
|
Sanofi
|
Chiesi Usa
Not the Allena Ji you were looking for?
Find accurate emails & phone numbers for over 700M professionals.
Work Experience

Chiesi Usa
Senior Director of Global Diagnostics & Science Affairs, Global Rare Diseases, Chiesi, USA
Sun May 01 2022 00:00:00 GMT+0000 (Coordinated Universal Time) — Present
Sanofi
Director, Biomarkers and Clinical Bioanalyses
Tue Mar 01 2016 00:00:00 GMT+0000 (Coordinated Universal Time) — Sun May 01 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Sanofi
Director, Operational Lab, Clinical Laboratory Sciences
Tue Jan 01 2013 00:00:00 GMT+0000 (Coordinated Universal Time) — Tue Mar 01 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Wuxi Apptec
Director of Bioanalytical Services
Thu Apr 01 2010 00:00:00 GMT+0000 (Coordinated Universal Time) — Tue Jan 01 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Pfizer
Associate Director, Bioanaltical R &D, DMPK
Tue Mar 01 2005 00:00:00 GMT+0000 (Coordinated Universal Time) — Thu Apr 01 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Pfizer
Principal Research Scientist
Wed Jan 01 2003 00:00:00 GMT+0000 (Coordinated Universal Time) — Tue Mar 01 2005 00:00:00 GMT+0000 (Coordinated Universal Time)
Pfizer
Senior Research Scientist
Fri Sep 01 2000 00:00:00 GMT+0000 (Coordinated Universal Time) — Wed Jan 01 2003 00:00:00 GMT+0000 (Coordinated Universal Time)
Kansas City Bioanalytical Services
Associate Director
Mon Sep 01 1997 00:00:00 GMT+0000 (Coordinated Universal Time) — Fri Sep 01 2000 00:00:00 GMT+0000 (Coordinated Universal Time)
Kansas City Bioanalytical Services
Asisstant Director
Fri Sep 01 1995 00:00:00 GMT+0000 (Coordinated Universal Time) — Mon Sep 01 1997 00:00:00 GMT+0000 (Coordinated Universal Time)